Asian Marco Initial Thoughts: Weakness in Markets Continues as Oil Rises. US Payrolls Could Add 'Fuel to the Fire' Tonight. Expect More Caution Ahead of the Weekend.

Key Takeaways

• Oil prices surge, tightening global inflation outlook
• Asian equities rebound, but sentiment remains neutral
• US payroll data could amplify market volatility
• Japan adds Kioxia, boosting Nikkei performance
• Taiwan launches $757M pharma resilience plan

Pulse Analysis

The escalation of the US‑Israel strike on Iran has pushed oil prices toward multi‑year highs, a development that reverberates across Asian equity markets. Higher crude costs feed into transportation and fertilizer expenses, squeezing profit margins for exporters and agribusinesses alike. Traders are watching the USD’s renewed strength as a hedge against commodity volatility, while European sovereign yields rise, reflecting broader risk‑off sentiment. In this environment, investors are recalibrating exposure to energy‑linked assets and reassessing inflation expectations.

Investor sentiment in the region is edging toward neutrality, a shift captured in the latest American Association of Individual Investors poll. The rise in bond yields across France, Italy, Germany, and the UK underscores concerns about fiscal pressures and the potential for tighter monetary policy. With the US non‑farm payrolls slated for release later today, market participants anticipate a possible catalyst for further volatility, especially if employment figures diverge sharply from forecasts. The ongoing de‑dollarisation narrative also shows signs of reversal as geopolitical uncertainty fuels demand for the greenback.

Corporate headlines add another layer of nuance. Japan’s Nikkei index will incorporate high‑growth names Kioxia and Pan Pacific, likely bolstering the benchmark’s performance amid record highs. South Korea’s Posco Future M is committing over $2 million to a synthetic‑graphite anode plant in Vietnam, positioning itself in the expanding battery‑materials supply chain. Meanwhile, Taiwan’s $757 million pharmaceutical resilience plan aims to safeguard drug supplies against geopolitical shocks, and the US approval of TerraPower’s small modular reactor marks a rare breakthrough in nuclear energy development. Together, these moves illustrate a strategic pivot toward sectors that can thrive amid heightened geopolitical risk and supply‑chain disruptions.